Description

Covilife MBD 275 Tablets combine two antiparasitic agents:

Ivermectin – widely used to treat infections caused by parasites such as worms and mites

Fenbendazole – a benzimidazole compound traditionally used in veterinary medicine, sometimes studied for antiparasitic applications

This combination is designed to target parasites through different mechanisms, potentially enhancing effectiveness. However, such combinations are not standard first-line treatments in humans and should only be used when prescribed by a qualified healthcare professional.

The formulation may be considered in specific clinical or experimental scenarios where a broader antiparasitic approach is required. Medical guidance is essential to ensure safety, appropriate dosing, and monitoring.

Usage Instructions

⚠️ Important: Use only under strict medical supervision

Take Covilife MBD 275 exactly as prescribed by your doctor.

Do not self-medicate or adjust dosage without professional advice.

Swallow the tablet with water.

Follow the specific dosing schedule provided by your healthcare provider.

Monitoring may be required during treatment.

Medicinal Advantages

When prescribed appropriately, this combination may offer:

Broad-spectrum antiparasitic coverage

Dual mechanism targeting parasites

Potential effectiveness in resistant or complex parasitic infections

May help reduce parasite load in certain conditions

⚠️ Clinical use in humans requires careful evaluation and is not routine.

Possible Side Effects

Possible side effects may include:

Nausea

Dizziness

Headache

Abdominal discomfort

Fatigue

Serious side effects may include allergic reactions, neurological symptoms, or liver-related issues. Immediate medical attention is required if severe symptoms occur.